ARVIND PHARMA LIMITED

Company number 09288695 ·

Active

Net assets, total assets & total liabilities 2016 – 2026

  • Total assets
  • Net assets
  • Total liabilities
-£250k £0 £250k £500k 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 Total assets 2016: £1,578 Total assets 2018: £74,763 Total assets 2019: £92,532 Total assets 2020: £138,576 Total assets 2021: £151,431 Total assets 2022: £214,445 Total assets 2023: £286,489 Total assets 2024: £321,757 Total assets 2025: £455,016 Total assets 2026: £451,668 Total assets Net assets 2016: £15 Net assets 2018: £33,697 Net assets 2019: £65,042 Net assets 2020: £96,215 Net assets 2021: £104,748 Net assets 2022: £125,759 Net assets 2023: £176,636 Net assets 2024: £194,998 Net assets 2025: £254,353 Net assets 2026: £323,002 Net assets Total liabilities 2016: -£1,563 Total liabilities 2018: -£41,066 Total liabilities 2019: -£27,490 Total liabilities 2020: -£42,361 Total liabilities 2021: -£46,683 Total liabilities 2022: -£88,686 Total liabilities 2023: -£109,853 Total liabilities 2024: -£126,759 Total liabilities 2025: -£200,663 Total liabilities 2026: -£128,666 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2025 – 2026

0 0 0 0 1 1 1 1 2 2025 2026 2025: 2 2026: 2

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 11 years

Latest accounts (2026-03-31): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2026-03-31 £451,668 -£128,666 £323,002 2
2025-03-31 £455,016 -£200,663 £254,353 2
2024-03-31 £321,757 -£126,759 £194,998
2023-03-31 £286,489 -£109,853 £176,636
2022-03-31 £214,445 -£88,686 £125,759
2021-03-31 £151,431 -£46,683 £104,748
2020-03-31 £138,576 -£42,361 £96,215
2019-03-31 £92,532 -£27,490 £65,042
2018-03-31 £74,763 -£41,066 £33,697
2016-10-31 £1,578 -£1,563 £15
2015-10-31 £3,450 -£3,435 £15

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.